MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Research It
- Compare Company
- International - miscellaneous
- DR. DATSONS LABS - ACTAVIS (US)
DR. DATSONS LABS vs ACTAVIS (US) - Comparison Results
ACTAVIS (US)
Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More
Financials
 DR. DATSONS LABS  ACTAVIS |
| EQUITY SHARE DATA | |||||
|---|---|---|---|---|---|
| DR. DATSONS LABS Mar-14 |
ACTAVIS Dec-18 |
DR. DATSONS LABS/ ACTAVIS |
5-Yr Chart Click to enlarge
|
||
| High | Rs | 126 | 14,478 | - | |
| Low | Rs | 31 | 9,712 | - | |
| Sales per share (Unadj.) | Rs | 133.0 | 3,551.4 | - | |
| Earnings per share (Unadj.) | Rs | 0.2 | -1,143.9 | - | |
| Cash flow per share (Unadj.) | Rs | 6.6 | 374.2 | - | |
| Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
| Dividend yield (eoy) | % | 0 | 0 | - | |
| Book value per share (Unadj.) | Rs | 128.8 | 14,647.7 | - | |
| Shares outstanding (eoy) | m | 31.66 | 332.60 | - | |
| Bonus/Rights/Conversions | FCCB | - | - | ||
| Price / Sales ratio | x | 0.6 | 3.4 | 17.3% | |
| Avg P/E ratio | x | 516.1 | -10.6 | -4,881.4% | |
| P/CF ratio (eoy) | x | 11.8 | 32.3 | 36.6% | |
| Price / Book Value ratio | x | 0.6 | 0.8 | 73.6% | |
| Dividend payout | % | 0 | 0 | - | |
| Avg Mkt Cap | Rs m | 2,477 | 4,022,682 | 0.1% | |
| No. of employees | `000 | NA | 16.9 | 0.0% | |
| Total wages/salary | Rs m | 56 | 0 | - | |
| Avg. sales/employee | Rs Th | NM | 69,892.5 | - | |
| Avg. wages/employee | Rs Th | NM | 0 | - | |
| Avg. net profit/employee | Rs Th | NM | -22,512.4 | - | |
| INCOME DATA | |||||
|---|---|---|---|---|---|
| Net Sales | Rs m | 4,211 | 1,181,183 | 0.4% | |
| Other income | Rs m | 79 | 22,588 | 0.3% | |
| Total revenues | Rs m | 4,289 | 1,203,771 | 0.4% | |
| Gross profit | Rs m | 569 | 30,953 | 1.8% | |
| Depreciation | Rs m | 204 | 504,930 | 0.0% | |
| Interest | Rs m | 430 | 68,161 | 0.6% | |
| Profit before tax | Rs m | 13 | -519,550 | -0.0% | |
| Minority Interest | Rs m | 0 | 0 | - | |
| Prior Period Items | Rs m | -2 | 0 | - | |
| Extraordinary Inc (Exp) | Rs m | 0 | 132,506 | 0.0% | |
| Tax | Rs m | 6 | -6,584 | -0.1% | |
| Profit after tax | Rs m | 5 | -380,460 | -0.0% | |
| Gross profit margin | % | 13.5 | 2.6 | 515.3% | |
| Effective tax rate | % | 48.0 | 1.3 | 3,790.1% | |
| Net profit margin | % | 0.1 | -32.2 | -0.4% | |
| BALANCE SHEET DATA | |||||
|---|---|---|---|---|---|
| Current assets | Rs m | 6,852 | 484,460 | 1.4% | |
| Current liabilities | Rs m | 6,711 | 428,569 | 1.6% | |
| Net working cap to sales | % | 3.3 | 4.7 | 70.8% | |
| Current ratio | x | 1.0 | 1.1 | 90.3% | |
| Inventory Days | Days | 161 | 20 | 821.3% | |
| Debtors Days | Days | 318 | 66 | 480.3% | |
| Net fixed assets | Rs m | 3,673 | 133,703 | 2.7% | |
| Share capital | Rs m | 317 | 0 | - | |
| Net worth | Rs m | 4,078 | 4,871,829 | 0.1% | |
| Long term debt | Rs m | 1,671 | 1,715,548 | 0.1% | |
| Total assets | Rs m | 12,633 | 7,615,778 | 0.2% | |
| Interest coverage | x | 1.0 | -6.6 | -15.5% | |
| Debt to equity ratio | x | 0.4 | 0.4 | 116.4% | |
| Sales to assets ratio | x | 0.3 | 0.2 | 214.9% | |
| Return on assets | % | 3.4 | -4.1 | -84.0% | |
| Return on equity | % | 0.1 | -7.8 | -1.5% | |
| Return on capital | % | 7.7 | -4.8 | -158.5% | |
| CASH FLOW | |||||
|---|---|---|---|---|---|
| From Operations | Rs m | 1,345 | 421,992 | 0.3% | |
| From Investments | Rs m | -2,256 | 231,830 | -1.0% | |
| From Financial Activity | Rs m | -1,200 | -724,265 | 0.2% | |
| Net Cashflow | Rs m | -2,111 | -70,091 | 3.0% | |
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 74.82 Rs / USD
Compare DR. DATSONS LABS With: ADCOCK INGRAM (S. Africa) MYLAN (US) TEVA PHARMA (Israel)
Compare DR. DATSONS LABS With: STRIDES PHARMA SCIENCE LUPIN FULFORD INDIA NOVARTIS SUVEN LIFE SCIENCES
Today's Market
Sensex Trades Marginally Higher, Dow Futures Down by 28 Points(12:30 pm)
Share markets in India are presently trading marginally higher. The BSE Sensex is trading up by 74 points, up 0.2% at 48,877 levels.
Related Views On News
Nazara Technologies IPO: Should You Apply? (IPO)
Mar 17, 2021Should you bet on this gaming company backed by ace investor Rakesh Jhunjhunwala?
More Views on NewsMost Popular
India: Recovery Stalled by Vaccine Games? (The Honest Truth)
Apr 13, 2021Ajit Dayal on how India's vaccine strategy will impact the markets.
4 Stocks to Make Your Portfolio Immune to the Second Covid Wave (Profit Hunter)
Apr 6, 2021Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.
An India Revival Stock I'm Bullish On... (Profit Hunter)
Apr 9, 2021This could take India to the position of 3rd largest economy.
Why Did the Market Crash on Monday? (Fast Profits Daily)
Apr 13, 2021In this video, I'll you what I think is the real reason behind yesterday's market crash.
Why the Market Fell Yesterday (Fast Profits Daily)
Apr 6, 2021In this video, I'll tell you the two reasons why the market fell on Monday and how you can prepare yourself for such events in the future.
More
